Cellectar Biosciences, Inc. (CLRB) vs Cocrystal Pharma, Inc. (COCP)
A side-by-side comparison of Cellectar Biosciences, Inc. and Cocrystal Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.67HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
COCP
Cocrystal Pharma, Inc.
$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CLRB vs COCP
growth of $100 · dividends reinvested · last 10yCLRB -100.0% (-55.5%/yr)COCP -99.4% (-39.6%/yr)COCP compounded faster over this window
Log scale — wide-divergence pair
CLRB COCP
CLRB vs COCP: by the numbers
- •COCP is the larger company ($15M vs $13M market cap).
- •Both run net losses; CLRB's is the smaller (0.00% vs -3011.52% net margin).
Metrics side by side
Valuation
| Metric | CLRB | COCP |
|---|---|---|
| P/S ratio | N/A | 46.38 |
| P/B ratio | 0.45 | 14.66 |
Profitability
| Metric | CLRB | COCP |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -3011.52% |
| ROE | -74.73% | -951.92% |
| ROIC | -74.94% | -497.29% |
Growth (annualized)
| Metric | CLRB | COCP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 91.55% |
| Total return CAGR (5Y) | -60.51% | -37.50% |
Frequently asked
- How have CLRB and COCP total returns compared?
- Over the past 10 years, CLRB delivered -55.35% and COCP delivered -39.76% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cellectar Biosciences ROECocrystal Pharma ROECellectar Biosciences operating marginCocrystal Pharma operating marginCellectar Biosciences revenue growthCocrystal Pharma revenue growthCellectar Biosciences free cash flowCocrystal Pharma free cash flow
Cellectar Biosciences & Cocrystal Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.